APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peramivir

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Peramivir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchPeramivir Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Peramivir Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Peramivir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peramivir Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Peramivir Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Peramivir market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Peramivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Peramivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peramivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Peramivir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Peramivir include BioCryst Pharmaceuticals, Green Cross Pharma, Hikma Pharmaceuticals, Moksha8 Pharma, NeoPharm, NT Pharma, SCOLR Pharma, Hunan Nucien Pharmaceutical Co., Ltd. and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Peramivir market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Peramivir and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Peramivir sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Peramivir market size, projected growth trends, production technologies, key applications, and end-use industries.

Peramivir Segment by Company

BioCryst Pharmaceuticals

Green Cross Pharma

Hikma Pharmaceuticals

Moksha8 Pharma

NeoPharm

NT Pharma

SCOLR Pharma

Hunan Nucien Pharmaceutical Co., Ltd.

Merck

Shionogi Co.

Peramivir Segment by Type

Solution

Solid

Peramivir Segment by Application

Influenza A Treatment

Influenza B Treatment

Peramivir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peramivir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peramivir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peramivir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Peramivir market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Peramivir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Peramivir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Peramivir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Peramivir Industry Trends Table 2. Peramivir Industry Drivers Table 3. Peramivir Industry Opportunities and Challenges Table 4. Peramivir Industry Restraints Table 5. Global Peramivir Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Peramivir Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Peramivir Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Peramivir Sales Market Share by Manufacturers Table 9. Global Peramivir Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Peramivir Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Peramivir Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Peramivir Manufacturers, Product Type & Application Table 13. Global Peramivir Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Peramivir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Solution Table 17. Major Manufacturers of Solid Table 18. Global Peramivir Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 19. Global Peramivir Sales by Type (2021-2026) & (Tons) Table 20. Global Peramivir Sales by Type (2027-2032) & (Tons) Table 21. Global Peramivir Sales Market Share by Type (2021-2026) Table 22. Global Peramivir Sales Market Share by Type (2027-2032) Table 23. Global Peramivir Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Peramivir Revenue by Type (2021-2026) & (Tons) Table 25. Global Peramivir Revenue by Type (2027-2032) & (Tons) Table 26. Global Peramivir Revenue Market Share by Type (2021-2026) Table 27. Global Peramivir Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Influenza A Treatment Table 29. Major Manufacturers of Influenza B Treatment Table 30. Global Peramivir Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 31. Global Peramivir Sales by Application (2021-2026) & (Tons) Table 32. Global Peramivir Sales by Application (2027-2032) & (Tons) Table 33. Global Peramivir Sales Market Share by Application (2021-2026) Table 34. Global Peramivir Sales Market Share by Application (2027-2032) Table 35. Global Peramivir Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 36. Global Peramivir Revenue by Application (2021-2026) & (Tons) Table 37. Global Peramivir Revenue by Application (2027-2032) & (Tons) Table 38. Global Peramivir Revenue Market Share by Application (2021-2026) Table 39. Global Peramivir Revenue Market Share by Application (2027-2032) Table 40. Global Peramivir Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 41. Global Peramivir Sales by Region (2021-2026) & (Tons) Table 42. Global Peramivir Sales Market Share by Region (2021-2026) Table 43. Global Peramivir Sales Forecasted by Region (2027-2032) & (Tons) Table 44. Global Peramivir Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Peramivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 46. North America Peramivir Sales by Country (2021-2026) & (Tons) Table 47. North America Peramivir Sales by Country (2027-2032) & (Tons) Table 48. Europe Peramivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 49. Europe Peramivir Sales by Country (2021-2026) & (Tons) Table 50. Europe Peramivir Sales by Country (2027-2032) & (Tons) Table 51. Asia Pacific Peramivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 52. Asia Pacific Peramivir Sales by Country (2021-2026) & (Tons) Table 53. Asia Pacific Peramivir Sales by Country (2027-2032) & (Tons) Table 54. South America, Middle East and Africa Peramivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. South America, Middle East and Africa Peramivir Sales by Country (2021-2026) & (Tons) Table 56. South America, Middle East and Africa Peramivir Sales by Country (2027-2032) & (Tons) Table 57. Global Peramivir Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Peramivir Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Peramivir Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Peramivir Revenue Market Share by Region (2021-2026) Table 61. Global Peramivir Revenue Market Share by Region (2027-2032) Table 62. BioCryst Pharmaceuticals Company Information Table 63. BioCryst Pharmaceuticals Business Overview Table 64. BioCryst Pharmaceuticals Peramivir Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. BioCryst Pharmaceuticals Peramivir Product Portfolio Table 66. BioCryst Pharmaceuticals Recent Development Table 67. Green Cross Pharma Company Information Table 68. Green Cross Pharma Business Overview Table 69. Green Cross Pharma Peramivir Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Green Cross Pharma Peramivir Product Portfolio Table 71. Green Cross Pharma Recent Development Table 72. Hikma Pharmaceuticals Company Information Table 73. Hikma Pharmaceuticals Business Overview Table 74. Hikma Pharmaceuticals Peramivir Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Hikma Pharmaceuticals Peramivir Product Portfolio Table 76. Hikma Pharmaceuticals Recent Development Table 77. Moksha8 Pharma Company Information Table 78. Moksha8 Pharma Business Overview Table 79. Moksha8 Pharma Peramivir Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Moksha8 Pharma Peramivir Product Portfolio Table 81. Moksha8 Pharma Recent Development Table 82. NeoPharm Company Information Table 83. NeoPharm Business Overview Table 84. NeoPharm Peramivir Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. NeoPharm Peramivir Product Portfolio Table 86. NeoPharm Recent Development Table 87. NT Pharma Company Information Table 88. NT Pharma Business Overview Table 89. NT Pharma Peramivir Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. NT Pharma Peramivir Product Portfolio Table 91. NT Pharma Recent Development Table 92. SCOLR Pharma Company Information Table 93. SCOLR Pharma Business Overview Table 94. SCOLR Pharma Peramivir Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. SCOLR Pharma Peramivir Product Portfolio Table 96. SCOLR Pharma Recent Development Table 97. Hunan Nucien Pharmaceutical Co., Ltd. Company Information Table 98. Hunan Nucien Pharmaceutical Co., Ltd. Business Overview Table 99. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product Portfolio Table 101. Hunan Nucien Pharmaceutical Co., Ltd. Recent Development Table 102. Merck Company Information Table 103. Merck Business Overview Table 104. Merck Peramivir Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Merck Peramivir Product Portfolio Table 106. Merck Recent Development Table 107. Shionogi Co. Company Information Table 108. Shionogi Co. Business Overview Table 109. Shionogi Co. Peramivir Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Shionogi Co. Peramivir Product Portfolio Table 111. Shionogi Co. Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Peramivir Distributors List Table 115. Peramivir Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Peramivir Product Image Figure 2. Global Peramivir Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peramivir Market Size (2021-2032) & (US$ Million) Figure 4. Global Peramivir Sales (2021-2032) & (Tons) Figure 5. Global Peramivir Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Peramivir Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Solution Image Figure 9. Solid Image Figure 10. Global Peramivir Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 11. Global Peramivir Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Peramivir Sales Market Share by Type (2021-2032) Figure 13. Global Peramivir Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Peramivir Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Peramivir Revenue Market Share by Type (2021-2032) Figure 16. Influenza A Treatment Image Figure 17. Influenza B Treatment Image Figure 18. Global Peramivir Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 19. Global Peramivir Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Peramivir Sales Market Share by Application (2021-2032) Figure 21. Global Peramivir Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Peramivir Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Peramivir Revenue Market Share by Application (2021-2032) Figure 24. North America Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 25. North America Peramivir Sales Market Share by Country (2021-2032) Figure 26. U.S. Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 27. Canada Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 28. Mexico Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 29. Europe Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Europe Peramivir Sales Market Share by Country (2021-2032) Figure 31. Germany Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 32. France Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 33. U.K. Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 34. Italy Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 35. Netherlands Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Asia Pacific Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Asia Pacific Peramivir Sales Market Share by Country (2021-2032) Figure 38. China Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 39. Japan Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 40. South Korea Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 41. Southeast Asia Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 42. India Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 43. Australia Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 44. South America, Middle East and Africa Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 45. South America, Middle East and Africa Peramivir Sales Market Share by Country (2021-2032) Figure 46. Brazil Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 47. South Africa Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 48. Saudi Arabia Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 49. Turkey Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Argentina Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 51. UAE Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 52. Egypt Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Chile Peramivir Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Global Peramivir Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Peramivir Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Peramivir Revenue (2021-2032) & (US$ Million) Figure 57. North America Peramivir Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Peramivir Revenue (2021-2032) & (US$ Million) Figure 59. Europe Peramivir Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Peramivir Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Peramivir Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Peramivir Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Peramivir Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Peramivir Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Peramivir Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Solution
  • Solid
Applications
  • Influenza A Treatment
  • Influenza B Treatment
Companies covered
  • BioCryst Pharmaceuticals
  • Green Cross Pharma
  • Hikma Pharmaceuticals
  • Moksha8 Pharma
  • NeoPharm
  • NT Pharma
  • SCOLR Pharma
  • Hunan Nucien Pharmaceutical Co., Ltd.
  • Merck
  • Shionogi Co.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Peramivir Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Peramivir Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Peramivir Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Peramivir Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Peramivir Market Dynamics
  1. 2.1 Peramivir Industry Trends
  2. 2.2 Peramivir Industry Drivers
  3. 2.3 Peramivir Industry Opportunities and Challenges
  4. 2.4 Peramivir Industry Restraints
3 Peramivir Market by Manufacturers
  1. 3.1 Global Peramivir Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Peramivir Sales by Manufacturers (2021-2026)
  3. 3.3 Global Peramivir Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Peramivir Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Peramivir Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Peramivir Manufacturers, Product Type & Application
  7. 3.7 Global Peramivir Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Peramivir Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Peramivir Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Peramivir Tier 1, Tier 2, and Tier 3
4 Peramivir Market by Type
  1. 4.1 Peramivir Type Introduction
  2. 4.1.1 Solution
  3. 4.1.2 Solid
  4. 4.2 Global Peramivir Sales by Type
  5. 4.2.1 Global Peramivir Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Peramivir Sales by Type (2021-2032)
  7. 4.2.3 Global Peramivir Sales Market Share by Type (2021-2032)
  8. 4.3 Global Peramivir Revenue by Type
  9. 4.3.1 Global Peramivir Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Peramivir Revenue by Type (2021-2032)
  11. 4.3.3 Global Peramivir Revenue Market Share by Type (2021-2032)
5 Peramivir Market by Application
  1. 5.1 Peramivir Application Introduction
  2. 5.1.1 Influenza A Treatment
  3. 5.1.2 Influenza B Treatment
  4. 5.2 Global Peramivir Sales by Application
  5. 5.2.1 Global Peramivir Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Peramivir Sales by Application (2021-2032)
  7. 5.2.3 Global Peramivir Sales Market Share by Application (2021-2032)
  8. 5.3 Global Peramivir Revenue by Application
  9. 5.3.1 Global Peramivir Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Peramivir Revenue by Application (2021-2032)
  11. 5.3.3 Global Peramivir Revenue Market Share by Application (2021-2032)
6 Global Peramivir Sales by Region
  1. 6.1 Global Peramivir Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Peramivir Sales by Region (2021-2032)
  3. 6.2.1 Global Peramivir Sales by Region (2021-2026)
  4. 6.2.2 Global Peramivir Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Peramivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Peramivir Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Peramivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Peramivir Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Peramivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Peramivir Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Peramivir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Peramivir Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Peramivir Revenue by Region
  1. 7.1 Global Peramivir Revenue by Region
  2. 7.1.1 Global Peramivir Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Peramivir Revenue by Region (2021-2026)
  4. 7.1.3 Global Peramivir Revenue by Region (2027-2032)
  5. 7.1.4 Global Peramivir Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Peramivir Revenue (2021-2032)
  8. 7.2.2 North America Peramivir Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Peramivir Revenue (2021-2032)
  11. 7.3.2 Europe Peramivir Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Peramivir Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Peramivir Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Peramivir Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Peramivir Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 BioCryst Pharmaceuticals
  2. 8.1.1 BioCryst Pharmaceuticals Company Information
  3. 8.1.2 BioCryst Pharmaceuticals Business Overview
  4. 8.1.3 BioCryst Pharmaceuticals Peramivir Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BioCryst Pharmaceuticals Peramivir Product Portfolio
  6. 8.1.5 BioCryst Pharmaceuticals Recent Developments
  7. 8.2 Green Cross Pharma
  8. 8.2.1 Green Cross Pharma Company Information
  9. 8.2.2 Green Cross Pharma Business Overview
  10. 8.2.3 Green Cross Pharma Peramivir Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Green Cross Pharma Peramivir Product Portfolio
  12. 8.2.5 Green Cross Pharma Recent Developments
  13. 8.3 Hikma Pharmaceuticals
  14. 8.3.1 Hikma Pharmaceuticals Company Information
  15. 8.3.2 Hikma Pharmaceuticals Business Overview
  16. 8.3.3 Hikma Pharmaceuticals Peramivir Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hikma Pharmaceuticals Peramivir Product Portfolio
  18. 8.3.5 Hikma Pharmaceuticals Recent Developments
  19. 8.4 Moksha8 Pharma
  20. 8.4.1 Moksha8 Pharma Company Information
  21. 8.4.2 Moksha8 Pharma Business Overview
  22. 8.4.3 Moksha8 Pharma Peramivir Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Moksha8 Pharma Peramivir Product Portfolio
  24. 8.4.5 Moksha8 Pharma Recent Developments
  25. 8.5 NeoPharm
  26. 8.5.1 NeoPharm Company Information
  27. 8.5.2 NeoPharm Business Overview
  28. 8.5.3 NeoPharm Peramivir Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 NeoPharm Peramivir Product Portfolio
  30. 8.5.5 NeoPharm Recent Developments
  31. 8.6 NT Pharma
  32. 8.6.1 NT Pharma Company Information
  33. 8.6.2 NT Pharma Business Overview
  34. 8.6.3 NT Pharma Peramivir Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NT Pharma Peramivir Product Portfolio
  36. 8.6.5 NT Pharma Recent Developments
  37. 8.7 SCOLR Pharma
  38. 8.7.1 SCOLR Pharma Company Information
  39. 8.7.2 SCOLR Pharma Business Overview
  40. 8.7.3 SCOLR Pharma Peramivir Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SCOLR Pharma Peramivir Product Portfolio
  42. 8.7.5 SCOLR Pharma Recent Developments
  43. 8.8 Hunan Nucien Pharmaceutical Co., Ltd.
  44. 8.8.1 Hunan Nucien Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Hunan Nucien Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product Portfolio
  48. 8.8.5 Hunan Nucien Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Peramivir Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck Peramivir Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Shionogi Co.
  56. 8.10.1 Shionogi Co. Company Information
  57. 8.10.2 Shionogi Co. Business Overview
  58. 8.10.3 Shionogi Co. Peramivir Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shionogi Co. Peramivir Product Portfolio
  60. 8.10.5 Shionogi Co. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Peramivir Value Chain Analysis
  2. 9.1.1 Peramivir Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Peramivir Production Mode & Process
  6. 9.2 Peramivir Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Peramivir Distributors
  9. 9.2.3 Peramivir Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst